Allison Serra, MD, MPH

Dr. Allison Serra is an Assistant Professor of Obstetrics, Gynecology, and Reproductive Sciences in the Division of Maternal Fetal Medicine. She earned her undergraduate degree in English at Duke University, her MPH in Health Policy from Emory University, and her MD from the University of North Carolina at Chapel Hill. Dr. Serra completed her residency in Obstetrics and Gynecology at the University of California, Irvine, and came to UPMC for her Maternal Fetal Medicine fellowship in 2015. She joined the faculty of the University of Pittsburgh in 2018. She has served as an Advisory Dean since 2021 and is the Director of Medical Student Mentoring and Advising in the Department of Obstetrics, Gynecology, and Reproductive Sciences. She has received numerous awards, including the Clerkship Preceptor of the Year and the prestigious Donald S. Fraley Award for Mentoring. Most significantly, back-to-back in 2022 and 2023, “House Serra” won the “House Cup,” which is awarded to the Pittmed advisory house with the highest level of student participation. Dr. Serra is grateful for the House Serra community and all the ways her students show up for each other.

As the Faculty Director of Program Evaluation, Dr. Serra is responsible for tracking measurable outcomes and identifying areas for improvement in the PittMed curriculum and was a member of the Curriculum Form Task Force that developed the Three Rivers Curriculum. Dr. Serra also leads CCQI, the Curriculum Committee’s Continuous Quality Improvement subcommittee, and in this role works closely with the OMED deans, faculty, staff, and students to evaluate and ensure quality in our curriculum. Dr. Serra has been involved in LCME accreditation since her time as a medical student at UNC, and loves to ask and answer the questions “How are we doing?” and “How can we do better?”

Dr. Serra is an active clinician in the division of Maternal Fetal Medicine within the Department of Obstetrics, Gynecology, and Reproductive Sciences and specializes in the care of people with complicated or “high risk” pregnancies.